782 material Form 8-K filings that 631 companies we cover made with the SEC in March 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Alliant Energy entered into a distribution agreement allowing it to sell up to $1 billion of common stock through a group of agents and forward purchasers, on March 19, 2026. The company says proceeds would be used for general corporate purposes, which may include debt repayment, working capital and construction and acquisition spending, and that no shares have been sold under the filing itself.
Program covers shares of common stock with an aggregate offering price of up to $1,000,000,000, sold on the Nasdaq Global Select Market or in block transactions.
The company may also enter into forward confirmations with forward purchasers; it would receive proceeds only upon physical settlement of those confirmations, on or before their maturity dates.
Shares are issued under Form S-3 Registration No. 333-276062 and a prospectus supplement dated March 19, 2026.
Several agents have affiliates that are lenders under the company's revolving credit facility.
Rush Enterprises said Chief Operating Officer Jason Wilder notified the company on March 18, 2026 that he will resign to pursue other opportunities, and that the resignation did not stem from any disagreement about operations, policies or practices. Director Michael J. McRoberts, a former COO now serving as Senior Advisor, will assist with COO duties and support the transition until the board appoints a new COO. The filing also furnishes an investor presentation that management plans to use with investors and analysts over the next couple of months.
Jason Wilder notified the company on March 18, 2026 of his decision to resign as Chief Operating Officer.
The filing states the resignation was not the result of any disagreement regarding the company's operations, policies or practices.
Michael J. McRoberts, a Board member and Senior Advisor, will assist with COO duties until the board appoints a new COO.
An investor presentation (Exhibit 99.1) will be used in meetings over the next couple of months and posted on the company's investor relations website.
Clear Secure said its General Counsel, Lynn Haaland, will leave the company on April 3, 2026. The company agreed to pay her an additional 12 months of salary in consideration for her services. The filing does not name a successor or describe the reasons for the departure.
General Counsel Lynn Haaland will depart on April 3, 2026
Company will provide an additional 12 months of salary to Ms. Haaland
Agreement reached March 19, 2026; filing signed by Chairman and CEO Caryn Seidman Becker
Collegium Pharmaceutical agreed to acquire the AZSTARYS ADHD medicine business from Corium Therapeutics for $650 million in cash, with up to $135 million more in milestone payments. The deal is expected to close in the second quarter of 2026 and will be funded with cash on hand and a $300 million delayed draw term loan. The company expects the deal to be immediately accretive to adjusted EBITDA and net leverage of about two times at closing, so shareholders will face a large cash outlay and new debt tied to the company's projections.
Purchase price of $650 million in cash at closing, plus up to $135 million in milestone payments tied to commercial and regulatory goals
Funded by existing cash on hand and a $300 million delayed draw term loan at SOFR plus 3.25% at closing
AZSTARYS expected to generate over $50 million in second half 2026 pro forma net revenue, per the press release
Closing expected in the second quarter of 2026; Collegium would pay a $24 million termination fee in specified circumstances
Eledon Pharmaceuticals reported its fourth quarter and full year 2025 results on March 19, 2026. The net loss for 2025 widened to $45.6 million from $36.2 million, driven by higher research and development expenses, though the loss per share narrowed to $0.52 from $0.66 on a larger share count.
Full-year 2025 net loss was $45.6 million, or $0.52 per basic share, versus $36.2 million, or $0.66 per share, in 2024.
Research and development expenses rose to $66.3 million from $52.0 million, which the company attributed to clinical trial activity, manufacturing scale-up and added personnel.
A non-cash gain of $33.4 million from changes in the fair value of warrant liabilities reduced the 2025 net loss; excluding warrant items, the net loss would have been $79.1 million.
Tidewater director Darron M. Anderson told the Board on March 17, 2026 that he will not stand for reelection at the 2026 Annual Meeting of Stockholders. He will remain a director and serve on the Audit Committee and Safety & Sustainability Committee until his current term ends, and the filing says his decision did not stem from any disagreement with the company. The Board will shrink from eight seats to seven.
Darron M. Anderson notified the Board on March 17, 2026 of his intent not to stand for reelection.
He will serve until his current term expires at the 2026 Annual Meeting.
He sits on the Audit Committee and Safety & Sustainability Committee.
Board size will be reduced from eight directors to seven.
Genelux entered into a Sales Agreement with TD Securities (USA) LLC (TD Cowen) that lets the company sell up to $100 million of common stock from time to time through TD Cowen as sales agent or principal. The company is not obligated to sell any shares and may suspend sales at any time, and it plans to use any proceeds for general corporate purposes, including research and development and clinical trial expenses.
Aggregate offering price of up to $100 million of common stock, par value $0.001 per share
TD Cowen compensation of up to 3.0% of gross proceeds from any shares sold, plus certain offering expenses
Sales are made under Form S-3 registration statement (File No. 333-276847), effective February 13, 2024, with a prospectus supplement to be filed March 19, 2026
Company is not required to sell any shares and may suspend sales at any time
Marvell Technology's Board declared a quarterly dividend of $0.06 per share, payable April 30, 2026 to stockholders of record as of April 10, 2026. The filing is a routine capital return announcement and does not include financial results or changes to guidance.
Quarterly dividend of $0.06 per share declared on March 19, 2026
Payable April 30, 2026 to stockholders of record as of April 10, 2026
Future dividends depend on results, cash balances, financial condition and Board discretion
AES disclosed three amendments to its credit and letter of credit agreements with Citibank, Sumitomo Mitsui Banking Corporation and Barclays Bank PLC, dated March 13 and March 16, 2026. The amendments modify change of control provisions to permit direct or indirect ownership of AES by Global Infrastructure Management, LLC, EQT Fund Management S.à r.l., Qatar Investment Authority and affiliated vehicles, following the March 2, 2026 merger agreement with Horizon Parent, L.P. The filing does not disclose dollar amounts for the facilities.
Citi Second Amendment dated March 13, 2026, with Citibank, N.A. as administrative agent
SMBC First Amendment dated March 16, 2026, with Sumitomo Mitsui Banking Corporation as administrative agent
Barclays First Amendment dated March 16, 2026, to a letter of credit agreement dated December 8, 2025
Amendments tied to the merger agreement announced March 2, 2026 with Horizon Parent, L.P.
Assured Guaranty's Chief Credit Officer, Stephen Donnarumma, notified the company on March 13, 2026 that he will retire effective September 30, 2026. He will then serve as a senior advisor to the CEO through April 2, 2027, which gives the company a transition period for the credit role.
Stephen Donnarumma notified the company of his retirement on March 13, 2026, effective September 30, 2026.
He will serve as a senior advisor to the Chief Executive Officer from October 1, 2026 until April 2, 2027.
He has been Chief Credit Officer of Assured Guaranty Ltd. since 2018 and of Assured Guaranty Inc. since 2007, and joined the company in 1993.
Sono Group N.V. said its supervisory board resolved on March 14, 2026 to end all current and future funding to its subsidiary Sono Motors GmbH and exit its legacy solar operations, citing a lack of profitability and no clear path to profitability. The same day, the company adopted a Treasury Strategy focused on buying and holding Bitcoin using a covered-call yield approach, which it projects will generate cash flow in the first year; the company says it cannot yet estimate the total costs of the exit, so shareholders face unquantified charges alongside the strategic shift.
Funding to Sono Motors GmbH was terminated with immediate effect; the decisions were made on March 14, 2026.
The company cannot yet make a good faith estimate of total costs and charges and will amend the filing when material amounts become reasonably estimable.
The Treasury Strategy centers on Bitcoin holdings using a covered-call yield strategy and is projected to generate cash flow in its first year.
The company plans to seek shareholder ratification of the Treasury Strategy at an extraordinary general meeting; no meeting date is given.
Aclarion's board adopted a limited duration stockholder rights plan on March 19, 2026, declaring a dividend of one right per common share and per Rights-Eligible Warrant to holders of record on March 30, 2026. The rights become exercisable only if a person or group acquires 10% or more of common stock without board approval, and the plan expires on March 18, 2027. The company states it was not adopted in response to any specific acquisition proposal, but the plan could make an unsolicited takeover more costly for a bidder.
Rights are exercisable at $14.00 per right, to buy one one-thousandth of a share of Series D Junior Participating Preferred Stock.
Rights become exercisable if a person or group acquires 10% or more of common stock in a transaction not approved by the Board.
Record date is March 30, 2026; the plan expires March 18, 2027, unless redeemed, exchanged or terminated earlier.
Board may redeem the rights at $0.001 per right; rights agent is VStock Transfer, LLC.
Marvell Technology filed a prospectus supplement to its automatic shelf registration statement on Form S-3 on March 19, 2026. The 8-K was filed to attach a legal opinion from Wilson Sonsini Goodrich & Rosati on the legality of the securities covered by that supplement. The filing does not state the amount or type of securities, so it does not by itself show a financial result or a change in the company's operations.
Prospectus supplement filed March 19, 2026 under Form S-3 registration No. 333-285742
Legal opinion from Wilson Sonsini Goodrich & Rosati attached as Exhibit 5.1
Filing made solely to file the legal opinion; no amount of securities is stated in this 8-K
FedEx reported third-quarter fiscal 2026 results for the quarter ended February 28, 2026, with revenue of $24.0 billion, up from $22.2 billion a year earlier, and GAAP diluted EPS of $4.41 versus $3.76. The company raised its fiscal 2026 EPS forecast before MTM retirement plan adjustments to $16.05 to $16.85 from $14.80 to $16.00, and says the FedEx Freight spin-off remains on track for June 1, 2026.
Q3 revenue $24.0 billion versus $22.2 billion; GAAP operating income $1.35 billion versus $1.29 billion
GAAP diluted EPS $4.41 versus $3.76; adjusted diluted EPS $5.25 versus $4.51
Fiscal 2026 EPS before MTM adjustments raised to $16.05 to $16.85 from $14.80 to $16.00; no GAAP EPS outlook provided
FedEx Freight spin-off on track for June 1, 2026; FedEx Freight issued $3.7 billion of senior notes on February 5, 2026
CVS Health's Board elected John E. Gallina, former Elevance Health CFO, as a director effective March 19, 2026, and appointed him to the Audit Committee. The Board determined he is independent, and the filing describes him as an audit committee financial expert.
Board elected John E. Gallina, age 66, effective March 19, 2026; Board action taken March 18, 2026
Gallina served as Elevance Health CFO from June 2016 through November 1, 2023, and retired in May 2024
Appointed to the Audit Committee and designated an audit committee financial expert under SEC rules
Compensation as a non-employee director will be consistent with other directors, prorated for his start date
GrowGeneration reported fourth-quarter and full-year 2025 results, with full-year net sales down to $161.7 million from $188.9 million after store closures, while the GAAP net loss narrowed to $24.0 million from $49.5 million. The company also gave 2026 guidance of $162 million to $168 million in revenue and breakeven Adjusted EBITDA, and its board authorized a share repurchase of up to $10 million of common stock.
Full-year 2025 net sales were $161.7 million, down from $188.9 million in 2024, reflecting retail store consolidations.
Full-year 2025 GAAP net loss was $24.0 million versus $49.5 million in 2024; Adjusted EBITDA loss was $6.0 million versus $14.5 million.
Board authorized repurchases of up to $10 million of common stock, which may begin after customary administrative and regulatory processes and may run for up to two years.
2026 outlook calls for revenue of $162 million to $168 million, gross margin of 27% to 29%, and breakeven Adjusted EBITDA for the full year.
LiveRamp Holdings disclosed that director Brian O'Kelley informed the Board on March 18, 2026, of his intention to resign, effective immediately. The company stated the resignation was not the result of a disagreement on its operations, policies or practices.
Brian O'Kelley had served as a LiveRamp director since 2023.
Resignation was communicated to the Board on March 18, 2026, and is effective immediately.
The filing states the departure was not due to a disagreement with the company on operations, policies or practices.
Reinsurance Group of America appointed Peter Babej, a former Citigroup executive, to its Board of Directors, effective April 1, 2026, increasing the Board to twelve directors. The filing discloses no financial results or transactions, so the change is a governance update rather than a financial event for shareholders.
Peter Babej, 62, appointed to the Board effective April 1, 2026, for a term ending at the 2026 annual meeting
Babej formerly served as CEO of Citi Asia, Chairman and Interim Head of Banking, and Global Head of Financial Institutions at Citigroup
Board size increases to twelve directors; he has not yet been named to any committees
The company reports no related-person transactions above $120,000 involving Babej since December 31, 2022
Scholastic reported fiscal third-quarter revenue of $329.1 million, down 2% from a year earlier, and an operating loss of $26.9 million compared with $23.9 million a year ago. Diluted earnings per share rose to $2.55 from a loss of $0.13, driven by a $119.8 million pretax gain on sale-leaseback transactions, and the company reaffirmed its full-year Adjusted EBITDA outlook of $146 million to $156 million. The board also authorized a $300 million share repurchase program, including a planned $200 million tender offer priced between $36 and $40 per share.
Revenue was $329.1 million, down 2% from $335.4 million; Adjusted EBITDA was $0.0 million versus $6.0 million a year earlier.
Operating loss was $26.9 million versus $23.9 million; net income of $62.5 million includes a $119.8 million pretax gain on sale-leaseback transactions.
Full-year Adjusted EBITDA outlook of $146 million to $156 million was reaffirmed, and full-year revenue is expected to be approximately flat.
A $200 million modified Dutch auction tender offer, priced at $36 to $40 per share, is anticipated to launch in the coming days.
Tripadvisor said on March 18, 2026 that Chair Greg Maffei and board member Albert Rosenthaler will not stand for re-election at the company's 2026 Annual Meeting of Shareholders. The filing says their decisions were not the result of any disagreement with the company on its operations, policies, or practices. The departures remove two board members, including the chair, and the board will need to address that change before or at the 2026 meeting.
Greg B. Maffei, Chair of the Board, notified the company and board on March 18, 2026 that he will not stand for re-election.
Albert E. Rosenthaler, a board member, gave the same notice on March 18, 2026.
The departures apply to the company's 2026 Annual Meeting of Shareholders.
The filing states the retirements were not the result of any disagreement with the company.
TCW Strategic Income Fund announced preliminary results of its transferable rights offering, which expired March 18, 2026 and was oversubscribed. The offer is expected to issue 15,928,480 new common shares for approximately $71 million in gross proceeds, which would increase the number of shares outstanding for existing holders.
Expected issuance of 15,928,480 common shares, including notices of guaranteed delivery
Subscription price of $4.47 per share, set at 88% of net asset value per share at the March 18, 2026 close
Anticipated gross proceeds of approximately $71 million; the Fund plans to invest net proceeds and added borrowings under its investment objective
Offer commenced February 19, 2026 and expired March 18, 2026; results are preliminary and subject to change
Camden Property Trust entered into a Fifth Amended and Restated Credit Agreement dated March 17, 2026, amending its existing credit facility. The revolving credit facility's maturity was extended from August 2026 to March 2030, with two possible six-month extensions at the company's option, and a $300 million unsecured term loan with a delayed draw feature was removed. The filing says proceeds will fund general corporate purposes, including debt repayment, development and acquisitions.
Revolving credit facility maturity extended from August 2026 to March 2030
Option to extend for two additional consecutive six-month periods
$300 million unsecured term loan facility with delayed draw feature removed
Bank of America, N.A. serves as Administrative Agent; a subsidiary guarantees the company's obligations
ACCESS Newswire reported fourth-quarter and full-year 2025 results, with full-year revenue down 2% to $22.6 million from $23.1 million in 2024. The loss from continuing operations narrowed sharply to $1.6 million from $13.3 million, mainly because 2024 included a $14.15 million impairment charge, and adjusted EBITDA rose to $3.2 million from $1.8 million.
Q4 2025 revenue was $5.8 million, flat versus Q4 2024 and up 1% from $5.7 million in Q3 2025.
Full-year 2025 revenue was $22.6 million, down 2% from $23.1 million in 2024, driven by lower PRO plan and webcasting and events revenue.
Q4 2025 net loss from continuing operations was $0.5 million, or $0.13 per diluted share, versus $10.9 million, or $2.85 per share, in Q4 2024.
Full-year 2025 net income was $4.3 million including discontinued operations, which included a $9.0 million gain on disposal of a business.
EchoStar and affiliates entered a Restructuring Support Agreement on March 19, 2026 with an ad hoc group holding more than 82% of DISH DBS notes. The company says the deal will significantly deleverage the business, and it includes dismissal of all pending litigation with prejudice between the company and noteholders.
RSA signed March 19, 2026 with an ad hoc group representing more than 82% of DDBS note holders
DBS SubscriberCo prepaid its 11.25% term loan and 13.75% preferred membership interests, totaling about $1.6 billion, on March 16, 2026
Company will prepay certain DDBS Notes without penalty; all pending litigation to be dismissed with prejudice
Titan Machinery reported fourth-quarter fiscal 2026 revenue of $641.8 million, down from $759.9 million a year earlier, while its net loss narrowed to $36.2 million from $43.8 million. For the full fiscal year, revenue fell to $2.4 billion from $2.7 billion and the net loss widened to $54.2 million, or $2.38 per diluted share, from $36.9 million, or $1.63 per share. The company also introduced fiscal 2027 modeling assumptions that point to a further decline in revenue in its Agriculture segment and a continued loss, which shareholders will weigh against the fiscal 2026 results.
Q4 fiscal 2026 net loss was $36.2 million, or $1.59 per diluted share, versus $43.8 million, or $1.93 per share, a year earlier; gross margin rose to 13.5% from 6.7%.
Full-year fiscal 2026 adjusted EBITDA was $13.9 million, up from $12.8 million in fiscal 2025, while reported net loss was $54.2 million.
Inventory fell $206 million in fiscal 2026, above the $150 million target, and the company says it has no further targeted inventory reductions planned for fiscal 2027.
Fiscal 2027 assumptions include adjusted EBITDA of $17.0 million to $29.0 million and adjusted diluted loss per share of $1.25 to $1.75, compared with an adjusted loss of $2.22 per share in fiscal 2026.
SOLV Energy reported fourth-quarter and full-year 2025 results, with full-year revenue of $2.49 billion versus $1.85 billion a year earlier and net income of $149 million versus $10 million. The company also initiated 2026 guidance calling for revenue of $3.72 billion to $3.82 billion and adjusted EBITDA of $400 million to $420 million, which gives shareholders a first forward view of the business after its IPO.
Q4 2025 revenue was $794 million versus $441 million in Q4 2024; Q4 gross margin was 18.1% versus 18.5%.
Full-year 2025 adjusted EBITDA was $342 million versus $165 million in 2024.
2026 guidance: revenue of $3.72 billion to $3.82 billion, gross profit of $580 million to $620 million, adjusted EBITDA of $400 million to $420 million.
Year-end 2025 backlog was $8 billion, up 87% from year-end 2024; the IPO raised $552.5 million in net proceeds.
Darden reported fiscal third-quarter 2026 sales of $3.3 billion, up 5.9%, with same-restaurant sales up 4.2%. Reported diluted EPS from continuing operations fell to $2.68 from $2.74, while adjusted EPS rose 5.4% to $2.95 after excluding impairment and strategic review costs. The company also updated its fiscal 2026 adjusted EPS outlook to $10.57 to $10.67 and declared a $1.50 quarterly dividend.
Q3 total sales rose 5.9% to $3.3 billion; same-restaurant sales rose 4.2%, with LongHorn Steakhouse up 7.2% and Olive Garden up 3.2%.
Reported diluted EPS from continuing operations was $2.68, down from $2.74; adjusted EPS was $2.95, up 5.4%, excluding $0.16 of restaurant closure impairment.
Fiscal 2026 adjusted EPS outlook is $10.57 to $10.67, including about $0.25 from a 53rd week.
Darden repurchased $127 million of stock in the quarter, with $516 million left under a $1 billion authorization; quarterly dividend of $1.50 per share is payable May 1, 2026.
Signet reported fourth-quarter sales of $2.35 billion and adjusted diluted EPS of $6.25, down from $6.62 a year earlier, while full-year adjusted diluted EPS rose to $9.60 from $8.94. The company introduced fiscal 2027 guidance calling for total sales of $6.6 billion to $6.9 billion and adjusted diluted EPS of $8.80 to $10.74, and raised its quarterly dividend to $0.35 per share. Shareholders get a dividend increase and a outlook, but the fourth-quarter adjusted profit decline and the planned James Allen transition, which the company says will cost $60 million to $80 million in net revenue, are factors to weigh.
Q4 sales of $2.35 billion, same store sales down 0.7%; adjusted diluted EPS $6.25 vs. $6.62 in Q4 of FY25
Full-year GAAP diluted EPS of $7.08 vs. a loss of $0.81 in FY25; adjusted diluted EPS $9.60 vs. $8.94
FY27 guidance: total sales $6.6 to $6.9 billion; adjusted diluted EPS $8.80 to $10.74
Quarterly dividend raised to $0.35 per share, payable May 22, 2026, to holders of record April 24, 2026
Accenture reported second-quarter fiscal 2026 revenue of $18.0 billion, up 8% in U.S. dollars and 4% in local currency, and diluted earnings per share of $2.93, up 4% from $2.82 a year earlier. The company raised its full-year free cash flow outlook to $10.8 billion to $11.5 billion and raised the low end of its revenue growth and GAAP earnings per share ranges, which matters to shareholders because it points to higher expected cash generation and profit.
Revenue of $18.04 billion, up 8% in U.S. dollars and 4% in local currency; new bookings of $22.11 billion, up 6% in U.S. dollars.
Diluted EPS of $2.93 versus $2.82 a year earlier; operating margin of 13.8% versus 13.5%.
Full-year fiscal 2026 local-currency revenue growth now expected at 3% to 5%, up from 2% to 5%; free cash flow now $10.8 billion to $11.5 billion, up from $9.8 billion to $10.5 billion.
Quarterly dividend of $1.63 per share, up 10%, payable May 15, 2026; $1.7 billion spent on share repurchases in the quarter.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.